{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"46"},{"groupId":"OG001","value":"43"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"52"},{"groupId":"OG001","value":"48"}],"units":"Participants"}],"description":"Overall remission rate as determined by the response at day 28, computed as the number of subjects with CR or Cri, in patients with newly diagnosed VHR B-ALL or high-risk relapse of B-ALL.","groups":[{"description":"Patients with newly diagnosed VHR B-ALL or high-risk relapse of B-ALL","id":"OG000","title":"Cohort A"},{"description":"Patients with poor response to prior B cell directed engineered cell therapy","id":"OG001","title":"Cohort B"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"28 Days","title":"Overall Remission Rate","type":"SECONDARY","unitOfMeasure":"Participants"}